Literature DB >> 6299955

Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

R D Dix, R R McKendall, J R Baringer.   

Abstract

Twenty-three strains of herpes simplex virus type 1 were compared for their pathogenicity in 4-week-old BALB/c mice after peripheral (footpad) or intracerebral inoculation. Among those strains examined were (i) six clinical isolates of brain or cerebrospinal fluid origin, (ii) seven clinical isolates of oral or genital origin, (iii) five prototype laboratory strains that have been passaged numerous times in culture, and (iv) five syncytial variants capable of producing cell fusion in culture. Based on comparative 50% lethal dose values, the strains appeared to segregate into one of three classes of neurovirulence. Class I strains were highly virulent by both the peripheral and intracerebral routes of inoculation, class II strains were highly virulent by the intracerebral route only, and class III strains were highly attenuated by both routes of inoculation. In vivo growth curves for whole brain homogenates infected with class III strains revealed titers of infectious virus approaching those found in the brains of animals infected with class I or II strains. These results would therefore suggest that (i) a strain-dependent variation in neural spread exists that may influence the ability of the virus to cause acute neurological disease and (ii) the amount of infectious virus present within an infected brain does not necessarily determine or reflect the clinical status of the animal. Of the clinical isolates examined, the strains recovered from brain tissue of humans after fatal episodes of encephalitis were found to be no more neurovirulent in mice than the strains isolated from nonneural sites. However, although syncytial variants were found to be highly attenuated by the peripheral route, as a group these strains proved to be among the most virulent when inoculated directly into the central nervous system.

Entities:  

Mesh:

Year:  1983        PMID: 6299955      PMCID: PMC264823          DOI: 10.1128/iai.40.1.103-112.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Different cytopathogenic effects observed in HeLa cells infected with herpes simplex virus.

Authors:  A GRAY; T TOKUMARU; T F M SCOTT
Journal:  Arch Gesamte Virusforsch       Date:  1958

Review 2.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

3.  Variability in the structural polypeptides of herpes simplex virus 1 strains: potential application in molecular epidemiology.

Authors:  L Pereira; E Cassai; R W Honess; B Roizman; M Terni; A Nahmias
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

4.  Herpes virus latency in spinal ganglia of mice without illness.

Authors:  R R McKendall; N Vogelzang; G G Jackson
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

5.  Herpes simplex encephalitis. Clinical Assessment.

Authors:  R J Whitley; S J Soong; C Linneman; C Liu; G Pazin; C A Alford
Journal:  JAMA       Date:  1982-01-15       Impact factor: 56.272

6.  Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.

Authors:  R Whitley; A D Lakeman; A Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

7.  Herpetic proctitis and meningitis: recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid.

Authors:  M Heller; R D Dix; J R Baringer; J Schachter; J E Conte
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

8.  Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.

Authors:  G Darby; H J Field; S A Salisbury
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

9.  Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection.

Authors:  J T Richards; E R Kern; J C Overall; L A Glasgow
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

10.  Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation.

Authors:  K Kristensson; A Vahlne; L A Persson; E Lycke
Journal:  J Neurol Sci       Date:  1978-02       Impact factor: 3.181

View more
  107 in total

1.  Truncation of herpes simplex virus type 2 glycoprotein B increases its cell surface expression and activity in cell-cell fusion, but these properties are unrelated.

Authors:  Zhenghong Fan; Michael L Grantham; M Shane Smith; Eric S Anderson; James A Cardelli; Martin I Muggeridge
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 2.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.

Authors:  W G Stroop; D C Schaefer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.

Authors:  Sita Awasthi; Elizabeth E Zumbrun; Huaxin Si; Fushan Wang; Carolyn E Shaw; Michael Cai; John M Lubinski; Shana M Barrett; John W Balliet; Jessica A Flynn; Danilo R Casimiro; Janine T Bryan; Harvey M Friedman
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.

Authors:  Y Nishiyama; H Kimura; T Daikoku
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties.

Authors:  Gregory J Wojaczynski; Esteban A Engel; Karina E Steren; Lynn W Enquist; J Patrick Card
Journal:  Brain Struct Funct       Date:  2014-03-02       Impact factor: 3.270

7.  Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.

Authors:  L I Strelow; D A Leib
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS79.

Authors:  Christopher D Bowen; Daniel W Renner; Jacob T Shreve; Yolanda Tafuri; Kimberly M Payne; Richard D Dix; Paul R Kinchington; Derek Gatherer; Moriah L Szpara
Journal:  Virology       Date:  2016-03-21       Impact factor: 3.616

9.  Pathologic studies and comparison of the virulence of herpes simplex virus type 2 from Okinawa, Japan and Chiang Mai, Thailand.

Authors:  K Sunagawa; W Sirirungsi; I Nakazato; T Hirayasu; T Iwamasa
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

10.  Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

Authors:  Harry Matundan; Kevin R Mott; Homayon Ghiasi
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.